Zenodo
Hepatitis C self-testing for people who inject drugs in South Africa and beyond: a catalytic innovation or red herring?
By Andrew Scheibe, Mark Wayne Sonderup, McBride Angela and 1 others.
Abstract
This commentary examines the potential contribution of hepatitis C self-testing to HCV elimination among people who inject drugs in South Africa and beyond. Drawing on implementation research, it discusses how high testing uptake can coexist with limited access to treatment and cure. It argues that self-testing must be embedded within accessible, decentralised HCV care and integrated harm reduction services, supported by domestic financing and action to address stigma and criminalisation. This is a preprint intended for publication in PLOS Global Public Health. It has not undergone peer review.
Keywords
- Hepatitis C virus research
- Open access
Source
This is a preprint: it has not been peer reviewed yet, and its findings may change.
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
